Eric P. Lefkofsky Sells 476,209 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 476,209 shares of the company’s stock in a transaction on Wednesday, January 22nd. The stock was sold at an average price of $49.84, for a total transaction of $23,734,256.56. Following the completion of the transaction, the chief executive officer now owns 6,502,643 shares of the company’s stock, valued at $324,091,727.12. This trade represents a 6.82 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Tempus AI Stock Down 6.3 %

NASDAQ TEM opened at $51.40 on Friday. The business’s 50-day moving average is $44.36 and its 200 day moving average is $47.68. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. Tempus AI, Inc. has a 1 year low of $22.89 and a 1 year high of $79.49.

Institutional Investors Weigh In On Tempus AI

Large investors have recently made changes to their positions in the business. abrdn plc purchased a new stake in Tempus AI in the fourth quarter worth $2,784,000. Renaissance Capital LLC raised its holdings in Tempus AI by 121.3% in the 4th quarter. Renaissance Capital LLC now owns 24,757 shares of the company’s stock worth $836,000 after purchasing an additional 13,569 shares in the last quarter. China Universal Asset Management Co. Ltd. purchased a new stake in shares of Tempus AI in the 4th quarter worth about $1,091,000. Exchange Traded Concepts LLC boosted its stake in shares of Tempus AI by 37.8% during the 4th quarter. Exchange Traded Concepts LLC now owns 84,174 shares of the company’s stock valued at $2,842,000 after purchasing an additional 23,070 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new position in shares of Tempus AI during the fourth quarter valued at about $372,000. 24.22% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on TEM shares. Wolfe Research started coverage on Tempus AI in a report on Friday, December 13th. They issued an “outperform” rating and a $60.00 price objective for the company. Piper Sandler reiterated a “neutral” rating and set a $70.00 price target (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Bank of America boosted their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Loop Capital reduced their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, January 14th. Finally, Stifel Nicolaus downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their price target for the stock from $45.00 to $65.00 in a research note on Monday, November 11th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $56.36.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.